| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |